rxstat › Shortages › Timolol Latanoprost

Timolol Latanoprost (Xalacom) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Sep 29, 2026

Some Timolol Latanoprost products are in shortage in Canada (4 of 9 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 30, 2027.

A combination eye drop containing a beta blocker and a prostaglandin, used to lower eye pressure in glaucoma.

Products affected
4 / 9
In shortage since
Aug 27, 2021
Est. full return
Jun 30, 2027
Reports on file
27
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
XALACOM
5MG 50MCG · SOLUTION · BGP PHARMA ULC
DIN 02246619 · since Sep 21, 2026, no end estimate · Demand increase for the drug.
Active shortage
LATANOPROST / TIMOLOL
5MG 50MCG · SOLUTION · JAMP PHARMA CORPORATION
DIN 02553848 · since Sep 15, 2026, est. end Oct 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-LATANOPROST/TIMOLOL
50MCG 5MG · SOLUTION · JAMP PHARMA CORPORATION
DIN 02453770 · since Mar 12, 2026, est. end Jun 30, 2027 · Demand increase for the drug.
Active shortage
ACT LATANOPROST/TIMOLOL
5MG 50MCG · SOLUTION · TEVA CANADA LIMITED
DIN 02436256 · since Aug 27, 2021, no end estimate · Disruption of the manufacture of the drug.
Resolved
MYLAN-LATANOPROST/TIMOLOL
50MCG 5MG · SOLUTION · MYLAN PHARMACEUTICALS ULC
DIN 02373068 · ended Sep 25, 2026 · Disruption of the manufacture of the drug.
Resolved
M-LATANOPROST-TIMOLOL
5MG 50MCG · SOLUTION · MANTRA PHARMA INC
DIN 02514516 · ended Jul 27, 2026 · Delay in shipping of the drug.
To be discontinued
TEVA-LATANOPROST-TIMOLOL
50MCG 5MG · SOLUTION · TEVA CANADA LIMITED
DIN 02436256
Resolved
MYLAN-LATANOPROST/TIMOLOL
50MCG 5MG · SOLUTION · MYLAN PHARMACEUTICALS ULC
DIN 02373068 · ended Jul 27, 2026 · Disruption of the manufacture of the drug.
Resolved
MYLAN-LATANOPROST/TIMOLOL
5MG 50MCG · SOLUTION · MYLAN PHARMACEUTICALS ULC
DIN 02373068 · ended Apr 23, 2026 · Demand increase for the drug.
Resolved
JAMP-LATANOPROST/TIMOLOL
50MCG 5MG · SOLUTION · JAMP PHARMA CORPORATION
DIN 02453770 · ended Apr 15, 2026 · Demand increase for the drug.
Resolved
MYLAN-LATANOPROST/TIMOLOL
50MCG 5MG · SOLUTION · MYLAN PHARMACEUTICALS ULC
DIN 02373068 · ended Apr 17, 2025 · Demand increase for the drug.
Resolved
M-LATANOPROST-TIMOLOL
5MG 50MCG · SOLUTION · MANTRA PHARMA INC
DIN 02514516 · ended Feb 27, 2025 · Delay in shipping of the drug.

Showing 12 of 27 reports. All reports are on file with Health Canada.

What's happening

Timolol Latanoprost is currently affected by 4 active shortage reports filed with Health Canada by BGP PHARMA ULC, JAMP PHARMA CORPORATION, TEVA CANADA LIMITED.

The reported causes are: demand increase for the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Timolol Latanoprost is classified under “ANTIGLAUCOMA PREPARATIONS AND MIOTICS” (ATC S01ED).

Recent changes

Common questions

What is Timolol Latanoprost used for?

A combination eye drop containing a beta blocker and a prostaglandin, used to lower eye pressure in glaucoma.

When will Timolol Latanoprost be back in stock in Canada?

The latest manufacturer estimate is Jun 30, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Timolol Latanoprost in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (antiglaucoma preparations and miotics)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Apraclonidine (Iopidine) No current shortage Dorzolamide (Trusopt) No current shortage Latanoprostene Bunod (Vyzulta) No current shortage Methazolamide No current shortage Timolol Brinzolamide No current shortage Acetazolamide Partial shortage 1 of 3 reported products affected · est. return Jan 1, 2027

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.